NO993315L - Raskt frigjörende og smaksmaskerende farmasöytisk doseringsform - Google Patents

Raskt frigjörende og smaksmaskerende farmasöytisk doseringsform

Info

Publication number
NO993315L
NO993315L NO993315A NO993315A NO993315L NO 993315 L NO993315 L NO 993315L NO 993315 A NO993315 A NO 993315A NO 993315 A NO993315 A NO 993315A NO 993315 L NO993315 L NO 993315L
Authority
NO
Norway
Prior art keywords
taste
dosage form
pharmaceutical dosage
coating layer
rapidly releasing
Prior art date
Application number
NO993315A
Other languages
English (en)
Norwegian (no)
Other versions
NO993315D0 (no
Inventor
Akinori Itoh
Toshiyuki Niwa
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO993315L publication Critical patent/NO993315L/no
Publication of NO993315D0 publication Critical patent/NO993315D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5015Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO993315A 1997-01-06 1999-07-05 Raskt frigjörende og smaksmaskerende farmasöytisk doseringsform NO993315D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB9700003 1997-01-06
PCT/IB1997/001471 WO1998030209A1 (en) 1997-01-06 1997-11-20 Rapidly releasing and taste-masking pharmaceutical dosage form

Publications (2)

Publication Number Publication Date
NO993315L true NO993315L (no) 1999-07-05
NO993315D0 NO993315D0 (no) 1999-07-05

Family

ID=11004515

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993315A NO993315D0 (no) 1997-01-06 1999-07-05 Raskt frigjörende og smaksmaskerende farmasöytisk doseringsform

Country Status (36)

Country Link
EP (1) EP0941075B1 (pt)
JP (1) JP3350059B2 (pt)
KR (1) KR20000069899A (pt)
CN (1) CN1244119A (pt)
AP (1) AP802A (pt)
AR (1) AR008553A1 (pt)
AT (1) ATE238776T1 (pt)
AU (1) AU715867B2 (pt)
BG (1) BG103541A (pt)
BR (1) BR9714253A (pt)
CA (1) CA2277017C (pt)
CO (1) CO4650099A1 (pt)
DE (1) DE69721559T2 (pt)
DK (1) DK0941075T3 (pt)
EA (1) EA199900521A1 (pt)
ES (1) ES2192265T3 (pt)
HN (1) HN1997000151A (pt)
HR (1) HRP980005A2 (pt)
HU (1) HUP0002744A3 (pt)
ID (1) ID21806A (pt)
IL (1) IL130582A0 (pt)
IS (1) IS5095A (pt)
MA (1) MA26464A1 (pt)
NO (1) NO993315D0 (pt)
NZ (1) NZ336251A (pt)
OA (1) OA11072A (pt)
PA (1) PA8443301A1 (pt)
PE (1) PE27999A1 (pt)
PL (1) PL334439A1 (pt)
SK (1) SK89599A3 (pt)
TN (1) TNSN98002A1 (pt)
TR (1) TR199901564T2 (pt)
UY (1) UY24835A1 (pt)
WO (1) WO1998030209A1 (pt)
YU (1) YU31599A (pt)
ZA (1) ZA9829B (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200591B1 (en) 1998-06-25 2001-03-13 Anwar A. Hussain Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction
DE19834506A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Transmucosales therapeutisches System zur Anwendung von Sildenafil
DE19834507A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Pharmazeutische, wasserlösliche Tablettenformulierung zur Anwendung von Sildenafil
UA67802C2 (uk) * 1998-10-23 2004-07-15 Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. Фармацевтична композиція з контрольованим вивільненням інгібітора цгмф фде-5 (варіанти), спосіб її одержання та спосіб лікування еректильної дисфункції
EP1133282A4 (en) * 1998-11-25 2006-03-29 Cima Labs Inc TASTE-MAKING DELIVERY SYSTEM WITH FAST RELEASE
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
US7501409B2 (en) 2000-09-06 2009-03-10 Mitsubishi Tanabe Pharma Corporation Preparations for oral administration
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
AR034813A1 (es) * 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
SE0202365D0 (sv) * 2002-08-05 2002-08-05 Pharmacia Ab New formulation and use thereof
US8039482B2 (en) 2004-03-25 2011-10-18 Astellas Pharma Inc. Composition of solifenacin or salt thereof for use in solid formulation
BG66010B1 (bg) * 2004-12-08 2010-10-29 "Софарма" Ад Лекарствена форма на силденафил
EP2098225B8 (en) * 2005-01-06 2011-06-22 Cima Labs Inc. Taste masking system for non-plasticizing drugs
US7815939B2 (en) 2005-07-20 2010-10-19 Astellas Pharma Inc. Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms
JPWO2007010930A1 (ja) * 2005-07-20 2009-01-29 アステラス製薬株式会社 口腔内崩壊製剤用の薬物含有被覆微粒子及びその製造方法
JP2007031407A (ja) 2005-07-29 2007-02-08 Shin Etsu Chem Co Ltd 低置換度セルロースエーテル含有コーティング用組成物及び不快な味が隠蔽されたフィルムコーティング製剤
US20070098746A1 (en) * 2005-11-02 2007-05-03 Nichols William M Multi-layered coating technology for taste masking
JP4602949B2 (ja) * 2006-08-02 2010-12-22 和光堂株式会社 被覆粒子含有組成物及びその製造方法
JPWO2008059881A1 (ja) * 2006-11-14 2010-03-04 サンスター株式会社 水溶性物質で表面処理された結晶セルロースを含む口腔用組成物
JP5777273B2 (ja) * 2008-07-10 2015-09-09 大正製薬株式会社 不快な呈味を有する薬物を含有する製剤粒子
US20100136110A1 (en) * 2008-09-30 2010-06-03 Astellas Pharma Inc. Granular pharmaceutical composition for oral administration
WO2010067140A1 (es) 2008-12-12 2010-06-17 Siegfried Rhein S.A. De C.V. Composicion de liberacion pulsatil de sildenafil y proceso para prepararla
DE102009016584A1 (de) 2009-04-06 2010-10-07 Ratiopharm Gmbh Schmelztablette, enthaltend ein Sildenafil-Salz
EP2524689B1 (en) * 2009-12-28 2016-10-05 Nipro Corporation Method for producing donepezil tablets
JP5226732B2 (ja) * 2010-05-20 2013-07-03 エスエス製薬株式会社 催眠用圧縮成型製剤
TWI462739B (zh) * 2010-11-02 2014-12-01 Univ Kaohsiung Medical Sildenafil-同族物四級銨哌嗪鹽類之製備及醫療用途
GB201119985D0 (en) * 2011-11-19 2012-01-04 Diurnal Ltd Treatment of adrenal insufficiency
CN103271940B (zh) * 2013-05-03 2014-03-12 湖北新济药业有限公司 复方金属离子补充剂及其制备方法
WO2017146052A1 (ja) * 2016-02-23 2017-08-31 ニプロ株式会社 医薬組成物粒子とそれを含む口腔内崩壊製剤、医薬組成物粒子の製造方法
EP3845219A4 (en) * 2018-08-28 2022-06-08 Towa Pharmaceutical Co., Ltd. ACTIVE PARTICLE
CN113559070B (zh) * 2021-08-18 2022-12-06 广州中冠动物药业有限公司 一种适用于宠物咳嗽的药物制备方法
CN116139088B (zh) * 2023-01-31 2024-04-16 南京海纳医药科技股份有限公司 一种含有枸橼酸西地那非的干混悬剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63258809A (ja) * 1987-04-16 1988-10-26 Towa Yakuhin Kk 医薬活性成分の放出性にすぐれ、かつ苦味を隠蔽した細粒剤
EP0458751A1 (en) * 1990-05-25 1991-11-27 Warner-Lambert Company Delivery system for cyclic amino acids with improved taste, texture and compressibility
JP2576927B2 (ja) * 1992-05-15 1997-01-29 ファイザー製薬株式会社 細粒核
JP3350054B2 (ja) * 1994-07-08 2002-11-25 アストラゼネカ・アクチエボラーグ 複数単位の錠剤化された剤形▲i▼

Also Published As

Publication number Publication date
AP9801173A0 (en) 1998-01-31
JP3350059B2 (ja) 2002-11-25
PL334439A1 (en) 2000-02-28
ID21806A (id) 1999-07-29
ATE238776T1 (de) 2003-05-15
MA26464A1 (fr) 2004-12-20
DK0941075T3 (da) 2003-07-14
OA11072A (en) 2002-02-27
IS5095A (is) 1999-06-25
JP2000514830A (ja) 2000-11-07
ES2192265T3 (es) 2003-10-01
HN1997000151A (es) 1997-12-20
TNSN98002A1 (fr) 2005-03-15
AU4880897A (en) 1998-08-03
EP0941075B1 (en) 2003-05-02
UY24835A1 (es) 2000-09-29
DE69721559T2 (de) 2003-11-27
NO993315D0 (no) 1999-07-05
ZA9829B (en) 1999-07-05
CN1244119A (zh) 2000-02-09
BG103541A (en) 2000-03-31
HUP0002744A2 (hu) 2000-12-28
BR9714253A (pt) 2000-04-18
AU715867B2 (en) 2000-02-10
EA199900521A1 (ru) 1999-12-29
NZ336251A (en) 2001-01-26
AP802A (en) 2000-01-21
WO1998030209A1 (en) 1998-07-16
PA8443301A1 (es) 2000-05-24
EP0941075A1 (en) 1999-09-15
YU31599A (sh) 2000-03-21
CA2277017A1 (en) 1998-07-16
DE69721559D1 (de) 2003-06-05
AR008553A1 (es) 2000-01-19
HRP980005A2 (en) 1998-10-31
CA2277017C (en) 2002-11-26
IL130582A0 (en) 2000-06-01
KR20000069899A (ko) 2000-11-25
TR199901564T2 (xx) 1999-09-21
SK89599A3 (en) 2000-12-11
HUP0002744A3 (en) 2001-01-29
CO4650099A1 (es) 1998-09-03
PE27999A1 (es) 1999-03-12

Similar Documents

Publication Publication Date Title
NO993315L (no) Raskt frigjörende og smaksmaskerende farmasöytisk doseringsform
NO20012222D0 (no) Farmasöytisk formulering innbefattende omeprazol
HUP0002524A2 (hu) Fekélyellenes hatóanyagot tartalmazó orális gyógyászati készítmények és eljárás azok előállítására
EE04218B1 (et) Toimeainena klodronaati ja ekstsipiendina ränistatud mikrokristallilist tselluloosi sisaldav farmatseutiline preparaat ning farmatseutilise preparaadi tootmismeetod
CO5271674A1 (es) Particulas farmaceuticas con enmascaramiento de sabor
SE9704869D0 (sv) New pharmaceutical formulaton II
EE200100505A (et) Modifitseeritud tärklise kasutamine hüdrofiilses kontrollitud vabanemisega preparaadis, hüdrofiilnekontrollitud vabanemisega preparaat, selle valmistamismeetod ja kasutamine ning ravimvorm
SE9702000D0 (sv) New pharmaceutical formulation
NO961136L (no) Farmasöytisk formuleringsgrunnlag for nano-suspensjoner
NO20083842L (no) Anvendelse av opploselig lymfotoksin-beta-reseptor for fremstilling av medikamenter
DK0977557T3 (da) Pelletpræparat til behandling af tarmkanalen
HUP0301591A2 (hu) Szabályozott hatóanyag-leadású hidrokodon-készítmények
ATE286387T1 (de) Clarithromycin enthaltende zubereitung mit verlängerter freisetzung
AU1495595A (en) Sustained-release dosage forms of alfuzosin hydrochloride
EP1177788A3 (en) Pharmaceutical composition of fluoxetin in coated dispersible tablets and process for its manufacture
WO2005039481A3 (en) Oral drug delivery system
HUP0500842A2 (hu) Dronedaront tartalmazó gyógyászati készítmény parenterális adagolásra
ES2170168T3 (es) Composiciones recubiertas entericamente de derivados de 1,5-benzodiacepina con actividad antagonista o agonista de cck.
DK0615446T3 (da) Retard-lægemiddel indeholdende et dihydropyridinderivat i nanosolform og fremstilling heraf

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application